MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien (MER.SW) Stock Competitors & Peer Comparison
See (MER.SW) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| MER.SW | CHF 102.20 | +0.00% | 0 | 14.20 | CHF 7.20 | N/A |
| SDZ.SW | CHF 60.46 | -0.07% | 26.2B | 36.42 | CHF 1.66 | +0.99% |
| EVT.SW | CHF 26.96 | N/A | 4.8B | -25.92 | -CHF 1.04 | N/A |
| SFZN.SW | CHF 73.50 | +0.41% | 3.2B | 19.14 | CHF 3.84 | +0.52% |
| PPGN.SW | CHF 26.70 | +1.14% | 881.3M | -45.25 | -CHF 0.59 | N/A |
| CURN.SW | CHF 21.00 | -1.87% | 108.2M | -75.00 | -CHF 0.28 | N/A |
| VIFN.SW | CHF 166.15 | +0.48% | 0 | N/A | N/A | N/A |
Stock Comparison
MER.SW vs SDZ.SW Comparison April 2026
MER.SW plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MER.SW stands at 0. In comparison, SDZ.SW has a market cap of 26.2B. Regarding current trading prices, MER.SW is priced at CHF 102.20, while SDZ.SW trades at CHF 60.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MER.SW currently has a P/E ratio of 14.20, whereas SDZ.SW's P/E ratio is 36.42. In terms of profitability, MER.SW's ROE is +0.05%, compared to SDZ.SW's ROE of +0.10%. Regarding short-term risk, MER.SW is less volatile compared to SDZ.SW. This indicates potentially lower risk in terms of short-term price fluctuations for MER.SW.Check SDZ.SW's competition here